{{Rsnum
|rsid=890749
|Chromosome=5
|position=122100901
|Orientation=minus
|GMAF=0.146
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 62.8 | 34.5 | 2.7
| HCB | 70.1 | 27.7 | 2.2
| JPT | 79.6 | 17.7 | 2.7
| YRI | 93.2 | 6.8 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 70.1 | 27.7 | 2.2
| CHD | 60.6 | 34.9 | 4.6
| GIH | 76.2 | 23.8 | 0.0
| LWK | 92.7 | 7.3 | 0.0
| MEX | 71.9 | 28.1 | 0.0
| MKK | 90.4 | 9.6 | 0.0
| TSI | 66.7 | 27.5 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=C
  |Pval=8E-6
  |OR=3.25
  |ORtxt=[1.82-4.68] mg/dL decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}